Literature DB >> 24974095

Reply to the letter by E. Savarino et al. regarding "The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders".

Yoshikazu Kinoshita1, Hiroto Miwa, Katsuyuki Sanada, Koji Miyata, Ken Haruma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24974095     DOI： 10.1007/s00535-014-0975-6

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  5 in total

1.  Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia.

Authors:  Yoshikazu Kinoshita; Hiroto Miwa; Katsuyuki Sanada; Koji Miyata; Ken Haruma
Journal:  J Gastroenterol       Date:  2013-05-08       Impact factor: 7.527

2.  Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.

Authors:  Takahisa Furuta; Tomohiko Shimatani; Mitsushige Sugimoto; Shunji Ishihara; Yasuhiro Fujiwara; Motoyasu Kusano; Tomoyuki Koike; Michio Hongo; Tsutomu Chiba; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2011-08-24       Impact factor: 7.527

3.  Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan.

Authors:  R Iwakiri; K Tominaga; K Furuta; M Inamori; T Furuta; H Masuyama; K Kanke; A Nagahara; K Haruma; Y Kinoshita; K Higuchi; S Takahashi; M Kusano; K Iwakiri; M Kato; M Hongo; H Hiraishi; S Watanabe; H Miwa; Y Naito; K Fujimoto; T Arakawa
Journal:  Aliment Pharmacol Ther       Date:  2013-08-20       Impact factor: 8.171

4.  The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.

Authors:  Nimish Vakil; Sander V van Zanten; Peter Kahrilas; John Dent; Roger Jones
Journal:  Am J Gastroenterol       Date:  2006-08       Impact factor: 10.864

5.  Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan.

Authors:  H Miwa; M Sasaki; T Furuta; T Koike; Y Habu; M Ito; Y Fujiwara; T Wada; A Nagahara; M Hongo; T Chiba; Y Kinoshita
Journal:  Aliment Pharmacol Ther       Date:  2007-07-01       Impact factor: 8.171
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.